Surgical Directions announced today that through its partnerships with health systems and provider groups across the country, more than 1 million patients were touched in 2025 by operational,...
– Japan now offers ELEVIDYS gene therapy to children with Duchenne muscular dystrophy aged 3 years to less than 8 years – Company is eligible to receive...
Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept...
Zentiva, a leading European manufacturer of high–quality and affordable medicines, responds to the decision of the General Court of the European Union concerning the Urban...